Prosecution Insights
Last updated: August 14, 2026
Application No. 18/280,046

HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, MANUFACTURING METHOD THEREFOR, AND COMPOSITION FOR ORGANIC LAYER

Non-Final OA §103
Filed
Sep 01, 2023
Priority
Mar 05, 2021 — RE 10-2021-0029686 +1 more
Examiner
COOPER, BRANDON JOSEPH
Art Unit
Tech Center
Assignee
LT Materials Co., Ltd.
OA Round
1 (Non-Final)
Grant Probability
Favorable
1-2
OA Rounds

Examiner Intelligence

Grants only 0% of cases
0%
Career Allowance Rate
0 granted / 0 resolved
-60.0% vs TC avg
Minimal +0% lift
Without
With
+0.0%
Interview Lift
resolved cases with interview
Typical timeline
Avg Prosecution
15 currently pending
Career history
13
Total Applications
across all art units

Statute-Specific Performance

§103
51.8%
+11.8% vs TC avg
§102
10.7%
-29.3% vs TC avg
§112
17.9%
-22.1% vs TC avg
Black line = Tech Center average estimate • Based on career data from 0 resolved cases

Office Action

§103
DETAILED ACTION Notice of Pre-AIA or AIA Status 1. The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Priority 2. Acknowledgment is made of applicant's claim for foreign priority based on applications filed in Korea on March 5, 2021. 3. Should applicant desire to obtain the benefit of foreign priority under 35 U.S.C. 119(a)-(d) prior to declaration of an interference, a certified English translation of the foreign application must be submitted in reply to this action. 37 CFR 41.154(b) and 41.202(e). 4. Failure to provide a certified translation may result in no benefit being accorded for the non-English application. Information Disclosure Statement 5. The references provided in the Information Disclosure Statements filed on September 1, 2023 and August 4, 2025 have been considered. Signed copies of the corresponding 1449 forms have been included with this office action. Specification 6. The disclosure is objected to because of the following informalities: the chemical structures provided in the list of compounds 1-180 beginning on pg. 41 of the instant specification are small, blurry, and difficult to read; and numerous depictions of chemical formulae and structures throughout the specification are of low resolution and difficult to read (see formulae on pgs. 19 and 26 of the instant specification as examples). 7. Appropriate correction is required. Claim Objections 8. Claim 4 is objected to because of the following informalities: the chemical structures provided in the list of compounds 1-180 are small, blurry, and difficult to read. 9. Claims 6-9 are objected to because of the following informalities: claim 5 recites “…one or more organic material layers…” while claims 6-9, which depend upon claim 5, recite “…wherein the organic material layer…” for the purposes of clarity, it is suggested that claims 6-9 instead recite “… wherein the one or more organic material layers…” 10. Appropriate correction is required. Claim Rejections - 35 USC § 103 11. In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. 12. The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. 13. The factual inquiries for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows: 1. Determining the scope and contents of the prior art. 2. Ascertaining the differences between the prior art and the claims at issue. 3. Resolving the level of ordinary skill in the pertinent art. 4. Considering objective evidence present in the application indicating obviousness or nonobviousness. 14. This application currently names joint inventors. In considering patentability of the claims the examiner presumes that the subject matter of the various claims was commonly owned as of the effective filing date of the claimed invention(s) absent any evidence to the contrary. Applicant is advised of the obligation under 37 CFR 1.56 to point out the inventor and effective filing dates of each claim that was not commonly owned as of the effective filing date of the later invention in order for the examiner to consider the applicability of 35 U.S.C. 102(b)(2)(C) for any potential 35 U.S.C. 102(a)(2) prior art against the later invention. 15. Claims 1-10 are rejected under 35 U.S.C. 103 as being unpatentable over DE 202013012401 U1 (hereinafter “App. ‘401”) in view of Sun et al. (CN 106083861 A; hereinafter “Sun”). 16. Regarding claim 1-4, App. ‘401 teaches compounds represented by Formula [1] (App. ‘401) (¶ [0016]-[0027]) that are useful as hole injection, hole transport, and/or exciton blocking materials in organic light emitting devices (¶ [0014]). 17. App. ‘401 teaches that compounds represented by Formula [1] have advantageous characteristics of at least: low sublimation temperature, high thermal and oxidative stability, and high glass transition temperatures which facilitates facile organic light emitting device fabrication (¶ [0123]); and high hole mobility (¶ [0123]); and affording high efficiency, low operating voltage, and long service lifetimes when used as a hole injection and/or hole transport material (¶ [0123]). 18. App. ‘401 discloses the following compound shown below represented by Formula [1] (App. ‘401 – see Formel 118: ¶ [0074] and compound 1-15: ¶ [0123], which are identical). PNG media_image1.png 469 816 media_image1.png Greyscale 19. Compound 1-15 of App. ‘401 reads on the limitations of Chemical Formulae 1 and 2 of claim 1 wherein: Ar1 and Ar2 are each independently unsubstituted C6 aryl groups; and R1-R4 and R6-R8 are each independently hydrogen atoms; and R5 is represented by Chemical Formula 2; and L is a direct bond and l is an integer equal to one; and La and Lb are direct bonds, and a and b are integers equal to one; and Ra and Rb are each independently unsubstituted C12 aryl groups. 20. Compound 1-15 of App. ‘401 fails to read on the limitation of Chemical Formula 1 wherein there is an alkynyl linker between Ar2 and position C9 of the fluorene group. 21. However, App. ‘401 does teach that each R1 of Formula [1] (App. ‘401) can be independently selected as: PNG media_image2.png 308 535 media_image2.png Greyscale C6-C30 aryl groups (¶ [0016]); and C2-C20 alkynyl groups which can be substituted with C6-C30 aryl groups (¶ [0016]). 22. Sun teaches organic light emitting materials and organic light emitting devices comprising the light emitting materials of Sun (pg. 1, Technical Field). 23. Sun teaches at least the following benefits of introducing an alkynyl linker within organic compounds wherein: the energy gap between the HOMO and LUMO levels of the compound comprising an alkynyl linker becomes smaller [pg. 1, Background of the Invention, (i)]; and hole and electron mobility are significantly increased because the introduction of alkynyl linker enables significant reduction of undesired hole and electron recombination [pg. 1, Background of the Invention, (iii)]; and hole and electron mobility of the compound comprising the alkynyl linker are also improved by an increase in the length of the conjugated system [pg. 1, Background of the Invention, (iv)]. 24. Therefore, it would have been obvious to one of ordinary skill in the pertinent art before the effective filing date of the claimed invention to introduce an alkynyl linker in compound 1-15 of App. ‘401, based on the teaching of Sun. The motivation for doing so would have been to minimize the energy gap between the HOMO and LUMO, and improve hole and electron mobility, as taught by Sun [pg. 1, Background of the Invention, (i), (iii), (iv)]. 25. Additionally, it would have been obvious to one of ordinary skill in the pertinent art before the effective filing date of the claimed invention to substitute one of the C6 aryl groups of compound 1-15 (App. ‘401, see circled area below) PNG media_image3.png 430 748 media_image3.png Greyscale with a C6 aryl-substituted alkynyl group, because it would have been choosing a specific location in compound 1-15 at which to include the alkynyl linker as a known group for R1 in Formula [1] (App. ‘401), which would have been a choice from a finite number of identified, predictable solutions of a compound useful as the hole injection and/or transport material in the hole injection and/or transport layers of the organic light emitting device of App. ‘401 and possessing the benefits taught by App. ‘401. One of ordinary skill in the art would have been motivated to produce additional compounds represented by Formula [1] (App. ‘401) having the benefits taught by App. ‘401 (low sublimation temperature, high thermal and oxidative stability, high glass transition temperatures, and high hole mobility, ¶ [0123]) in order to pursue the known options within his or her technical grasp with a reasonable expectation of success. See MPEP 2143.I.(E). 26. The modified compound 1-15 (App. ‘401, Sun) resulting from the alkynyl introduction discussed above is shown below. PNG media_image4.png 360 401 media_image4.png Greyscale 27. Per claim 1, the modified compound 1-15 (App. ‘401, Sun) reads on all of the limitations of Chemical Formulae 1 and 2 wherein: Ar1, Ar2, R1-R8, L, La, Lb, l, a, b, Ra, and Rb are all the same as previously defined. 28. Per claim 2, the modified compound 1-15 (App. ‘401, Sun) reads on all of the limitations of Chemical Formula 2-1 wherein: L, La, Lb, l, a, and b are the same as previously defined; and R11 and R12 are each independently unsubstituted C12 aryl groups. 29. Per claim 3, Chemical 2-2 is not required to be present, as per claim 2, and thus the limitation is met. 30. Per claim 4, the modified compound 1-15 (App. ‘401, Sun) reads on the limitation wherein it is identical to compound 136. 31. Regarding claims 5-10, App. ‘401 teaches an organic light emitting device (¶ [0168]-[0175]) comprising: a first electrode (ITO, ¶ [0169]); and a second electrode (Al, ¶ [0169]); and one or more organic material layers provided between the first electrode and the second electrode (HIL, HTL, EBL, EML, ETL ¶ [0169]); and one or more layers of the organic material layers comprise the heterocyclic compound of any one of claim 1 (¶ [0172], [0174]-[0175]). 32. App. ‘401 specifically teaches compound 1-15 (App. ‘401) in the EBL of an organic light emitting device (Table 1, Example E9). 33. While App. ‘401 teaches the compound 1-15 (App. ‘401) in the EBL of an organic light emitting device and generally teaches uses of the compounds disclosed therein in an organic light emitting device of claim 5, App. ‘401 does not specifically teach the modified compound 1-15 (App. ‘401, Sun) in an organic light emitting device. 34. At the time the invention was effectively filed, it would have been obvious to one of ordinary skill in the art to have modified the organic light emitting device of App. ‘401 by substituting compound 1-15 (App. ‘401) with modified compound 1-15 (App. ‘401, Sun) in the EBL of App. ‘401, based on the teaching of App. ‘401 (low sublimation temperature, high thermal and oxidative stability, high glass transition temperatures, and high hole mobility, ¶ [0123]). The modification would have been a combination of prior art elements according to known methods to yield predictable results. See MPEP 2143(I)(A). 35. Per claims 5, 7, and 10, the modified organic light emitting device of App. ‘401, comprising modified compound 1-15 (App. ‘401, Sun) in the EBL reads on all of the limitations as previously described. 36. Per claim 6 and 9, the modified organic light emitting device of App. ‘401, comprising modified compound 1-15 (App. ‘401, Sun) in the EBL reads on the limitations of claim 6 wherein the EBL has the same function as an HTL (to facilitate the effective transport of holes), and claim 9 wherein the EBL has the same function as an HIL (to facilitate the effective transport of holes). 37. Per claim 8, the modified organic light emitting device of App. ‘401, comprising modified compound 1-15 (App. ‘401, Sun) in the EBL reads on the limitation in that the light emitting auxiliary layer, as per the definition provided on pg. 52 of the instant specification, has the function of facilitating hole transfer, hole injection, and electron blocking, which is the same as the EBL. Conclusion 38. Any inquiry concerning this communication or earlier communications from the examiner should be directed to Brandon J. Cooper whose telephone number is (571)272-0005. The examiner can normally be reached Monday - Friday 8:30 AM - 5:00 PM. 39. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. 40. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Jennifer Boyd can be reached at (571) 272-7783. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. 41. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /B.J.C./Examiner, Art Unit 1786 /BRAELYN R WATSON/Primary Examiner, Art Unit 1786
Read full office action

Prosecution Timeline

Sep 01, 2023
Application Filed
Jul 28, 2026
Non-Final Rejection mailed — §103 (current)

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
Grant Probability
Low
PTA Risk
Based on 0 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month